Skip to content
  • Research
    • Drug Science Journal
    • Peer Reviewed Publications
    • Reports
    • Articles
  • Twenty21
    • Join as a Patient
    • Find out more
    • Updates
    • Resources
    • Prescribers
  • Learn
    • Books
    • Education
    • Events
    • Podcast
    • Videos
  • Drug Info
    • Cannabinoids
    • Depressants
    • Opioids
    • Psychedelics
    • Stimulants
  • Working Groups
    • Medical Cannabis
    • Medical Psychedelics
    • Enhanced Harm Reduction
  • About
    • Our Story
    • Team
    • Committee
    • Students
    • Community
Donate

Keep up with developments in drug science

Reading, engaging with, and sharing our publications, papers and commentary gives evidence-based science and policy the audience it needs and deserves.

  1. Home
  2. Blogs

Blogs

Project Twenty21 - August Update

August 17 2022

The Drug Enforcement Agency listens to psychedelic experts

August 5 2022

Comparative harms assessments for cannabis, alcohol, and tobacco: Risk for psychosis, cognitive impairment, and traffic accident

July 25 2022

State naloxone co-prescribing laws show mixed effects on overdose mortality rates

July 25 2022

Project Twenty21 - July Update

July 12 2022

Diamorphine-Assisted Treatment

July 11 2022

The Misuse of Drugs Regulations 2001: A case study in poor legislative drafting

July 11 2022

User perceptions of the benefits and harms of hallucinogenic drug use: A web-based questionnaire study

July 7 2022

Over One Hundred Years of MDMA Research

June 29 2022

Professor Sir Colin Blakemore and Drug Science

June 28 2022

Cannabinoids and the endocannabinoid system in fibromyalgia: a review of preclinical and clinical research

June 21 2022

Amend the Misuse of Drugs Regulations to pilot overdose prevention centres in the UK

June 15 2022
  • Privacy Policy
  • Terms and conditions
  • Cookie policy
  • Contact
Facebook Twitter Linkedin Instagram YouTube

© 2022 Drug Science. All rights reserved